Why switch from protease inhibitors (PI) to non-nucleoside reverse transcriptase inhibitors (NNRTI)?

Pozniak, A L

Why switch from protease inhibitors (PI) to non-nucleoside reverse transcriptase inhibitors (NNRTI)? [electronic resource] - HIV medicine 2000 - 7-10 p. digital

Publication Type: Journal Article; Review

1464-2662

10.1046/j.1468-1293.2000.00006.x doi


Anti-HIV Agents--therapeutic use
Drug Therapy, Combination
HIV Infections--drug therapy
HIV-1--drug effects
Humans
Protease Inhibitors--adverse effects
Reverse Transcriptase Inhibitors--therapeutic use
Treatment Outcome